RxDoctor Payments Data

Sheryl Drew, APRN

Emergency Medicine · Deland, FLNPI 1154096543

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $992 of the $1,107 with a category attached, or 89.6%. 12 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 27.6% of the total. 2025 is the largest year on record at $847, 9.5 times the $90 reported in 2022. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,107in general payments, 2019–2025

Across 28 payments — averaging $39.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$306
  • AstraZeneca$283
  • Eisai Inc.$172
  • Nevro Corp.$115
  • Xeris Pharmaceuticals, Inc.$46
  • Pfizer$41
  • plus $145 from 6 others

What the payments were for

  • Travel & lodging$11510%
  • Food & beverage$99290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,107 in reported general payments places this provider in the 90th percentile of 3,289 emergency medicine providers in Florida.

See all emergency medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$2,361
Medicare patients
19
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amitriptyline Hcl20$628
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort11$589
Fluticasone Propionate60$583
Ibuprofen88$321
Albuterol Sulfate HfaAlbuterol Sulfate16$301
Doxycycline Hyclate30$268
Methocarbamol42$256
Azithromycin30$236
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$207
Prednisone90$168
Levofloxacin14$147
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$132
Ciprofloxacin Hcl16$128
Pantoprazole Sodium13$90
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$56

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Deland

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →